A2 STEAM Partnership

We’re excited to announce a new partnership with the Ann Arbor Public Schools STEAM educators and students! As partners we are looking forward to creating opportunities for students and educators, as well as DDF team members, to explore topics in pharmaceutical sciences, career pathways and higher-education opportunities.

Check back often for new projects and happenings as we continue to work with the amazing Ann Arbor Public Schools community!

In Vivo Predictive Dissolution (iPD) Conference Rescheduled, Expanded

Ann Arbor, MI, February 9th, 2017: The in vivo Predictive Dissolution (iPD) Conference 2017, hosted by the Drug Delivery Foundation (www.ddfint.org) and originally proposed to be held at the University of Michigan August 7th – 9th, 2017, has been rescheduled and expanded to a four and a half day workshop March 5th – 9th, 2018, in Lake Tahoe, CA.

The rescheduling and expansion of the iPD conference was done to not conflict with the upcoming AAPS workshop in September and to provide more extensive education and training for implementing a science-based mechanistic Formulation Predictive Dissolution (fPD) methodology for a Pharmaceutical Product Development environment.

Details of the iPD-fPD four and a half day workshop will be available by September 2017, which will follow the format of the Oral Drug Delivery conference series that have been sponsored by the Drug Delivery Foundation over the past 30 years. 

Read the full press release here.

About the Drug Delivery Foundation: We serve as an international, not-for-profit organization for promoting education, training and research in the drug delivery field. We have provided training to industry, regulatory, and academic scientists and organizations.

DDF to Sponsor Workshop on BCS Drug Evaluation & Bioequivalence

La Habana, Cuba, September 12th, 2016: The Drug Delivery Foundation will be co-sponsoring a workshop titled "BCS Drug Evaluation and Bioequivalence in conjunction with the Center of Genetic Engineering and Biotechnology and the Cuban Society of Pharmacology.

This course will offer a scientific program focused in BCS application with a focus on scientists working in drug development and medicines evaluation. Content includes lectures and hands on BCS, including methods for estimating and evaluating drug intestinal absorption, dissolution test and IVIVC.

The course will run from September 12th to September 14th. Send an e -mail to macabreraster@gmail.com to receive full information about the course. A full schedule is available here.

Center of Genetic Engineering and Biotechnologyhttp://www.cigb.edu.cu/

Cuban Society of Pharmacologyhttp://www.scf.sld.cu/

About the Drug Delivery Foundation: We serve as an international, not-for-profit organization for promoting education, training and research in the drug delivery field. We have provided training to industry, regulatory, and academic scientists and organizations.

 

Special Issue of the Journal of Pharmaceutical Sciences Dedicated to Professor Gordon Amidon

A special edition of the Journal of Pharmaceutical Sciences was recently dedicated to Professor Gordon Amidon. The edition honors his many contributions to the pharmaceutical sciences, particularly in oral drug absorption. Gordon Amidon, PhD, Charles R. Walgreen Jr. Professor of Pharmacy and Pharmaceutical Sciences, is best known for his establishment of the Biopharmaceutics Classification System (BCS), which is currently in use by the U.S. Food and Drug Administration, as well as internationally, for classification and regulation of pharmaceuticals.

Read the full issue here!

Gordon Amidon Presented with Honorary Doctorate at Miguel Hernández University

US researcher Gordon Amidon has been invested Doctor Honoris Causa Wednesday by Miguel Hernández (UMH) University of Elche (Alicante). The UMH and recognizes their work on the prediction of drug absorption in humans. The event took place coinciding with the celebration of the feast of St. Thomas.

Read full story here: http://www.laverdad.es/alicante/elche/201501/28/inviste-como-doctor-honoris-20150128102059.html